| Julienne K. Kirk, PharmD |
Associate Professor
Department of Family & Community Medicine
 “My personal interests are scuba diving, water skiing, gardening and aerobics. I also enjoy calligraphy and exploring the outdoors.” |
|
Interests |
Diabetes, Education Interventions, Outcomes for Minority Populations |
|
Education |
1986 | University of North Carolina
Chapel Hill, NC
B.S. Degree, Pharmacy |
1991 | University of North Carolina
Chapel Hill, NC
Pharm.D. Degree |
|
Postdoctoral Training |
1991 – 1992 | ASHP-Accredited Specialty Residency
Clinical Pharmacokinetics
University of North Carolina Hospitals
Chapel Hill, NC |
|
Certifications |
1993 | Board Certified Pharmacotherapy Specialist
Recertified 2000, 2007 |
1993 | Certified Diabetes Educator
Recertified 2000, 2005 |
2008 | Cardiopulmonary Resuscitation Certification
American Heart Association |
|
Academic Career |
1992 – 1995 | Instructor
Department of Family & Community Medicine
Wake Forest University School of Medicine
Winston-Salem, NC |
1992 – 1995 | Assistant Director, Pharmacy Education
Northwest Area Health Education Center
Winston-Salem, NC |
1995 – 1999 | Associate Director, Pharmacy Education
Northwest Area Health Education Center
Winston-Salem, North Carolina |
1995 – 2001 | Assistant Professor
Department of Family & Community Medicine
Wake Forest University School of Medicine
Winston-Salem, NC |
2001 – present | Associate Professor
Department of Family & Community Medicine
Wake Forest University School of Medicine
Winston-Salem, NC |
|
Current Projects |
|
Southeast Network Action to Control Cardiovascular Risk in Diabetes (ACCORD) |
This is a multi-center study designed to assess the effect of tight glycemic control and aggressive risk factor management on the risk of cardiovascular disease in persons with Type-2 diabetes mellitus. |
Source | NIH / NIDDK |
Timeframe | 2000 – 2009 |
Role | Certified Diabetes Educator |
|
Clinical Trial of Vildagliptin |
A randomized, double-Blind, active-controlled, multicenter study to compare the effect of 24 Weeks Treatment With a Fixed Combination Therapy of vildagliptin and metformin to the individual monotherapy components in drug naïve patients With Type-2 diabetes. |
Source | Novartis Pharmaceuticals |
Funding | $97,000 |
Timeframe | 2006 – present |
Role | Co-Investigator |
|
NAVIGATOR Study |
Study of the Efficacy and Safety of Long-Term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects with Impaired Glucose Tolerance (IGT). |
Source | Novartis Pharmaceuticals |
Funding | $200,000 |
Timeframe | 2002 – 2009 |
Role | Co-Investigator |
|
Rural Elder's Diabetes Self Management: Development of a Common Sense Model Inventory |
The purpose of this research is to delineate the common sense of diabetes held by older rural adults, determine the source of variability in these common sense models, including gender and ethnicity, develop the Common Sense Model Inventory (CSMI), and establish the validity and reliability of this instrument. |
Source | NIH / NIA |
Funding | $299,489 |
Timeframe | 2006 – present |
Role | Co-Investigator |
|
Physician Assistants Meeting Vulnerable Patients' Health Literacy Needs |
The goal of this research is to graduation PA with skills to assess patient's health literacy level and to implement tailored educational interventions to care for at risk patients. |
Source | Health Resources and Services Administration (HRSA) |
Funding | $265,170 |
Timeframe | 2007 – present |
Role | Co-Investigator |
|
Selected Publications |
Kirk JK, Poirier JE, Mattox MG, Thomas PM, Michielutte R. Compliance with national guidelines in patients with diabetes in a family practice clinic. Pharmacotherapy. 2002;22:1541-1546. |
Kirk JK, Nichols M, Spangler JG. Use of peripheral dexa measurement for osteoporosis screening. Fam Med 2002;34:201-205. |
Barringer TA, Kirk JK, Santaniello AC, Long KM, Michielutte R. Effect of a multivitamin and mineral supplement on infection and quality of life. A randomized, double-blind, placebo-controlled trial. Ann Int Med 2003;138:365-371. |
Bertoni AG, Kirk JK, Goff DC, Wagenknect LE. Excess mortality related to diabetes mellitus in elderly Medicare beneficiaries. Ann Epidemiol 2004;14:362-367. |
Kirk JK, Hepfinger C. Calcitonin. Clin Rev Bone Min Met 2005;3:39-49. |
Kirk JK, Bell RA, Bertoni AG, Arcury TA, Quandt SA, Goff DC, Narayan KMV. A qualitative review of studies of diabetes preventive care among minority patients in the United States, 1993-2003. Am J Managed Care 2005;11:21-32. |
Kirk JK, Bell RA, Bertoni AG, Arcury TA, Quandt SA, Goff DC, Narayan KMV. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Ann Pharmacotherapy 2005;39:1489-1501. |
Bertoni AG, Kirk JK, Case D, Goff DC, Narayan KMV, Bell RA, et al. The effects of race and region on cardiovascular morbidity among elderly Americans with diabetes. Diabetes Care 2005;28:2620-2625. |
Kirk JK, Huber K, Clinch CR. Attainment of goals from national guidelines among persons with type 2 diabetes: a cohort study in an academic family medicine setting. .NC Med J 2005;66:415-419. |
Graves DE, White JC, Kirk JK. The use of insulin glargine with gestational diabetes. Diabetes Care 2006;29:471-472. |
Kirk JK, D’Agostino RB, Bell RA, Passmore, Bond D, Kartar AJ, Narayan KMV. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: A meta-analysis. Diabetes Care 2006;29:2130-2136. |
Kirk JK, Graves DE, Bell RA, Hildebrandt C, Narayan KMV. Racial and ethnic disparities in self-monitoring of blood glucose among US adults: A qualitative review. Ethnicity Dis 2007;17:135-142. |
Kirk JK, Raggio GA, Nesbit BA, Davis SW, Minalko SL, Miller GD, Sevick MA. Individualized enhanced adherence intervention study in adults with diabetes. J Diabetes Sci Technol 2007;2:451-452. |
Gerstein HC, Riddle M, Kendall D, Cohen R, Goland R, Feinglos MN, Kirk JK, Hamilton BP, Feeney P. Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007;99:34-43. |
Kirk JK. Disparities in diabetes care among minority populations. Exp Rev Endocrin Metabol 2007;2:425-427. |
Kirk JK, Bell RA, Bertoni AG, Case LD, Goff DC, Narayan KMV. Predicted risk of coronary heart disease among persons with type 2 diabetes. Coron Artery Dis 2007:18:.595-600. |
Marion GS, Crandall SJ, Celestino F, McCann W, Kirk JK. Cultivating patient-centered communication skills training across the medical education continuum: A model for practice. NC Med J 2007;68:356-358. |
Kirk JK, Bell RA, Bertoni AG, Case LD, Goff DC, Narayan KMV. Predicted risk of coronary heart disease among persons with type 2 diabetes. Coron Artery Dis 2007:18:.595-600. |
Kirk JK, Graves DE, Craven TE, Lipkin EW, Austin MA, Margolis KL. Restricted carbohydrate diets in patients with type 2 diabetes: A meta-analysis. J Am Diet Assoc 2008;108:91-100. |
Kirk JK, Passmore LV, Bell RA, Narayan KMV, Arcury TA, Quandt SA. Disparities in A1C levels between Hispanics and Non-Hispanic white adults with diabetes: A meta-analysis. Diabetes Care 2008;31:240-246. |
|
| | |